SCHEMBL29515916

SCHEMBL29515916

N#Cc1cc2c(cc1Br)CNCC2

nearest known ligand 0.53

Predicted protein targets (top 14)

geneUniProtsupporting neighboursconfidence
▸ PNMT P11086 10/20 0.53
▸ DRD2 P14416 2/20 0.53
▸ DRD3 P35462 2/20 0.53
▸ ASIC3 Q9UHC3 1/20 0.47
▸ HTR2A P28223 2/20 0.41
▸ HTR2C P28335 2/20 0.41
▸ HTR2B P41595 2/20 0.41
▸ ADRA2A P08913 2/20 0.40
▸ ADRA2B P18089 2/20 0.40
▸ ADRA2C P18825 2/20 0.40
▸ CD44 P16070 1/20 0.37
▸ MAOB P27338 1/20 0.37
▸ S1PR1 P21453 1/20 0.37
▸ S1PR3 Q99500 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28109514 0.81 PNMT (0.61) PNMTDRD2DRD3ASIC3HTR2A
SCHEMBL25324819 0.79 PNMT (0.53) PNMTDRD2DRD3ASIC3HTR2A
SCHEMBL30474289 0.79 PNMT (0.53) PNMTDRD2DRD3ASIC3HTR2A
Hydrochloric Acid SCHEMBL7641237 0.78 PNMT (0.51) PNMTDRD2DRD3ASIC3HTR2A
SCHEMBL15301098 0.74 ALDH1A1 (0.49) PNMTDRD2DRD3HTR2AHTR2C
SCHEMBL18554679 0.73 PRCP (0.51) PNMTDRD2DRD3ASIC3ADRA2A
SCHEMBL28999502 0.73 PNMT (0.50) PNMTDRD2DRD3HTR2AHTR2C
SCHEMBL31391697 0.73 PNMT (0.50) PNMTDRD2DRD3HTR2AHTR2C
SCHEMBL31139061 0.73 PNMT (0.52) PNMTDRD2DRD3ASIC3HTR2A
SCHEMBL3004226 0.73 PNMT (0.52) PNMTDRD2DRD3ASIC3HTR2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4240363-A1 7-PHENYL SUBSTITUTED 2-AMINOQUINAZOLINE INHIBITORS OF HPK1 Merck Sharp & Dohme LLC (US) 2023-09-13 — — EP disclosed
WO-2022098806-A1 7-PHENYL SUBSTITUTED 2-AMINOQUINAZOLINE INHIBITORS OF HPK1 MERCK SHARP & DOHME CORP. (US) 2022-05-12 — — WO disclosed
Send feedback